Sens. Bill Cassidy (R-LA), Michael Bennet (D-CO), Chuck Grassley (R-IA), Tom Carper (D-DE), Todd Young (R-IN) and Claire McCaskill (D-MO) are seeking guidance from health care stakeholders as they develop legislation to improve price transparency in the health care market and lower costs. In a letter yesterday to health care, patient and business groups, including the AHA, the senators request feedback by March 23 on questions ranging from what consumer price and quality information is or should be available, who should be responsible for providing and sharing price information, and how to avoid creating unnecessary or additional burdens. The senators plan to host roundtable conversations with a variety of experts in the coming weeks, and are also engaging the administration, members of Congress and governors. AHA plans to submit comments.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The AHA Dec. 19 submitted comments on the Department of Homeland Security’s proposed rule regarding the Public Charge Ground of Inadmissibility, urging the…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase…
Headline
The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…